Fundación Para La Investigación Del Hospital Clínico De Valencia
Clinical trials sponsored by Fundación Para La Investigación Del Hospital Clínico De Valencia, explained in plain language.
-
Potassium binder may unlock lifesaving heart drugs for seniors
Disease control Recruiting nowThis study tests whether a potassium-lowering drug (SZC) can help elderly patients (70+) with heart failure and chronic kidney disease safely increase their doses of RAASi medications, which are often limited by high potassium levels. About 94 participants will be randomly assign…
Phase: PHASE3 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
Pacemaker study aims to boost stamina in heart failure patients
Symptom relief Recruiting nowThis study looks at whether a pacemaker can improve exercise ability and quality of life in people with heart failure with preserved ejection fraction (HFpEF) who also have a small heart chamber and a low heart rate during activity. Thirty participants will receive a pacemaker an…
Phase: NA • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated May 17, 2026 00:43 UTC
-
Iron infusion may boost Seniors' recovery after heart attack
Symptom relief Recruiting nowThis study tests whether giving intravenous iron to adults aged 65 and older with iron deficiency after a heart attack can improve their quality of life and reduce frailty. About 538 participants will be randomly assigned to receive either the iron infusion or standard care, and …
Phase: PHASE4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated May 17, 2026 00:30 UTC